Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.32 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2521267 | 0.91 | — | — | |
| SCHEMBL15577119 | 0.88 | POLB (0.32) | POLBCASP3SENP7SENP6NPC1 | |
| SCHEMBL1986436 | 0.87 | — | — | |
| SCHEMBL8162849 | 0.87 | POLB (0.33) | POLBCASP3SENP7SENP6NPC1 | |
| SCHEMBL28866167 | 0.76 | — | — | |
| SCHEMBL14034413 | 0.73 | — | — | |
| SCHEMBL28356901 | 0.71 | — | — | |
| SCHEMBL3421402 | 0.71 | — | — | |
| SCHEMBL23544595 | 0.71 | — | — | |
| SCHEMBL7138226 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062725-A1 | METHOD FOR PURIFYING (-)-AMBROX | GIVAUDAN SA (CH) | 2026-03-05 | — | — | US | disclosed |
| US-20260043058-A1 | SHC ENZYMES AND ENZYME VARIANTS | GIVAUDAN SA (CH) | 2026-02-12 | — | — | US | disclosed |
| US-12404531-B2 | Method for purifying (−)-Ambrox | GIVAUDAN SA (CH) | 2025-09-02 | — | — | US | disclosed |
| US-20230212624-A1 | METHOD FOR PURIFYING (-)-AMBROX | GIVAUDAN SA (CH) | 2023-07-06 | — | — | US | disclosed |
| US-20230021613-A1 | SQUALENE HOPENE CYCLASE (SHC) VARIANTS | GIVAUDAN SA (CH) | 2023-01-26 | — | — | US | disclosed |
| US-20210254112-A1 | ENZYMES AND APPLICATIONS THEREOF | GIVAUDAN SA (CH) | 2021-08-19 | — | — | US | disclosed |
| US-10472655-B2 | Enzymes and applications thereof | GIVAUDAN S.A. (CH) | 2019-11-12 | — | — | US | disclosed |
| US-20180148751-A1 | ENZYMES AND APPLICATIONS THEREOF | GIVAUDAN SA (CH) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180148751-A1 | ENZYMES AND APPLICATIONS THEREOF | HAO1, HLCS, HACL2 | POLB 226/4885CASP3 4395/4885SENP7 815/4885 |
| US-20210254112-A1 | ENZYMES AND APPLICATIONS THEREOF | HAO1, HLCS, HACL2 | POLB 226/4885CASP3 4395/4885SENP7 815/4885 |
| US-20260043058-A1 | SHC ENZYMES AND ENZYME VARIANTS | SQLE, DHCR7, CYP51A1 | POLB 774/4885CASP3 3480/4885SENP7 1898/4885 |
| US-20260062725-A1 | METHOD FOR PURIFYING (-)-AMBROX | TAS2R7, TAS2R3, TAS2R13 | POLB 187/4885CASP3 441/4885SENP7 2396/4885 |
| US-10472655-B2 | Enzymes and applications thereof | HAO1, HLCS, HACL2 | POLB 226/4885CASP3 4395/4885SENP7 815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.